A source familiar with the Biogenesis investigation tells HardballTalk that if Alex Rodriguez and Major League Baseball are unable to reach a settlement in connection with the Biogenesis matter, Major League Baseball will suspend Rodriguez for life. Previous reports have only suggested such a move is possible.
A lifetime ban would almost certainly cause Rodriguez to appeal the discipline. HardballTalk’s source says that Major League Baseball is aware that the arbitrator who would hear the matter – Fredric Horowitz – may not uphold a lifetime ban in light of the fact that Rodriguez has never been subject to discipline for PEDs before and because going all the way to baseball’s most severe sanction would be extreme for first-time discipline. The league believes, however, that even if he were successful in having his sanction reduced on appeal, Rodriguez would ultimately be given a severe suspension, on par with what it is currently offering Rodriguez: 150 games or greater. The league is confident that Rodriguez would not prevail on the basic matter of culpability if he appealed.
Major League Baseball was unable to comment, citing the pendency on the ongoing investigation. Rodriguez’s attorney, David Cornwell, did not return calls seeking comment.
The source says that Major League Baseball is unwilling to agree to a suspension of Rodriguez in the 100-game range, demanding much more time off, even in the context of a settlement. The league, according to the source, believes that it has “compelling evidence” of significant malfeasance on Rodriguez’s part, including use of performance enhancing drugs, steering other players who sought to take PEDs to the Biogenesis clinic and his attempts to obtain and possibly destroy evidence from the Biogenesis clinic. Rodriguez and his attorneys, the source says, strongly dispute allegations of steering players to Biogenesis and attempting to destroy evidence.
The source says that, those disputes aside, Rodriguez is “in for a world of hurt.”
The source says that discipline is most likely to be leveled against Rodriguez, be it in the form of a settled-on or unilaterally-imposed sanction on Friday. Major League Baseball is expected to announce discipline for all of the other players connected to Biogenesis on that day as well.
Yahoo Sports’ Jeff Passan reports that third baseman Jose Ramirez is finalizing a four-year extension with the Indians. The deal is said to be worth north of $30 million, and may crest $50 million if all options are exercised. While the extension won’t take effect until the 2018 season, it guarantees Ramirez a $26 million sum with two options worth $11 and $13 million and will give the Indians control of the infielder through the 2023 season.
Ramirez, 24, is entering his fifth season in the Indians’ organization. He posted career-high numbers during his first full season in the majors, slashing .312/.363/.461 with 11 home runs, 22 stolen bases and 4.8 fWAR in 2016. He’s projected to have a strong follow-up season at the plate and will likely see some time at second base as Jason Kipnis works his way back from a shoulder injury.
Although 2016 only showcased the beginning of Ramirez’s success with the club, FanRag Sports’ Jon Heyman says it’s a standard move for Cleveland to “sign their stars early,” and indicates that Ramirez was rumored to want the deal. Jeff Todd of MLB Trade Rumors adds that the extension will keep Ramirez under club control through three arbitration-eligible years and one year of potential free agency.
Diamondbacks’ right-hander Tyler Jones is headed back to the Yankees, the teams announced on Friday. The Diamondbacks had previously selected Jones in the Rule 5 draft last December, but elected to leave the 27-year-old off of their 40-man roster heading into the 2017 season. Rule 5 draft rules stipulate that when a player is not kept on the receiving team’s roster, the player must be offered back to his original team.
Jones signed a minor league contract with the Yankees prior to the 2016 season. He pitched to an impressive 2.17 ERA, 2.2 BB/9 and 13.2 SO/9 over 45 2/3 innings with Double-A Trenton, but was unable to make the leap to Triple-A or beyond during his stay with the organization.
Jones’ outlook with the Diamondbacks appeared slightly more promising. GM Mike Hazen described the righty as a power arm with a “good fastball and power curveball” after selecting him in the Rule 5 draft, and early reports indicated that Jones would be in the mix for a bullpen spot. A rough spring performance — underscored by his lack of experience at the Triple-A and major league levels — undid most of that confidence, however, and the Diamondbacks weren’t willing to keep him on the active roster throughout the entire 2017 season in order to acquire his control rights.
Jones is set to open the season with Triple-A Scranton/Wilkes-Barre, per a report from the Yankees.